Morning Briefing
Summaries of health policy coverage from major news organizations
Sanofi Pasteur's Dengue Vaccine Enters Phase III Trial In Australia
Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports. "Sanofi-Aventis already performed earlier clinical tests on children and adults with the vaccine in the U.S., Asia and Latin America," Dow Jones/Wall Street Journal adds (Landauro, 11/4).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
